摘要
Early surgical intervention for lymphedema can delay,prevent,and even reverse lymphatic degeneration.Vascularized lymph vessel transplant(VLVT)has emerged as an alternative to vascularized lymph node transplant(VLNT)for the treatment of advanced,fluid-predominant lymphedema,providing highly favorable outcomes with reduced donor-site complications.Lymphaticovenular anastomosis(LVA)has traditionally been reserved for early disease.However,technical refinements have improved its results and expanded its efficacy,creating an overlap between the indications for VLVT/VLNT and LVA.This article describes our technical approach to VLVT and LVA and explores the nuances of treatment selection in the light of their shifting indications.
